Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marit M van Buuren

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|April 10, 2013
Human cancer regression antigensPia Kvistborg, Marit M van Buuren, Ton N Schumacher
Cancer Cell|January 14, 2015
Biomarkers in cancer immunotherapyTon N Schumacher, Can Kesmir, Marit M van Buuren
Oncoimmunology|August 2, 2014
High sensitivity of cancer exome-based CD8 T cell neo-antigen identificationMarit M van Buuren, Jorg Ja Calis, Ton Nm Schumacher
Cancer Immunology Research|February 21, 2019
Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell ActivityPaula Kroon, Elselien Frijlink, Victoria Iglesias-Guimarais, et al.
Science (New York, N.Y.)|May 21, 2016
Targeting of cancer neoantigens with donor-derived T cell receptor repertoiresErlend Strønen, Mireille Toebes, Sander Kelderman, et al.
Genome Medicine|August 15, 2020
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopesAsaf Poran, Dewi Harjanto, Matthew Malloy, et al.
Cell Reports Methods|May 13, 2025
Generation of T cell responses against broad KRAS hotspot neoantigens for cell therapy or TCR discoveryBrandon P Conn, Jared L Dietze, Christian J Yee, et al.
European Journal of Immunology|March 24, 2016
Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapySander Kelderman, Bianca Heemskerk, Lorenzo Fanchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2013
HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responsesMarit M van Buuren, Feline E Dijkgraaf, Carsten Linnemann, et al.
Nature Medicine|December 23, 2014
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanomaCarsten Linnemann, Marit M van Buuren, Laura Bies, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|April 10, 2013
Human cancer regression antigensPia Kvistborg, Marit M van Buuren, Ton N Schumacher
Cancer Cell|January 14, 2015
Biomarkers in cancer immunotherapyTon N Schumacher, Can Kesmir, Marit M van Buuren
Oncoimmunology|August 2, 2014
High sensitivity of cancer exome-based CD8 T cell neo-antigen identificationMarit M van Buuren, Jorg Ja Calis, Ton Nm Schumacher
Cancer Immunology Research|February 21, 2019
Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell ActivityPaula Kroon, Elselien Frijlink, Victoria Iglesias-Guimarais, et al.
Science (New York, N.Y.)|May 21, 2016
Targeting of cancer neoantigens with donor-derived T cell receptor repertoiresErlend Strønen, Mireille Toebes, Sander Kelderman, et al.
Genome Medicine|August 15, 2020
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopesAsaf Poran, Dewi Harjanto, Matthew Malloy, et al.
Cell Reports Methods|May 13, 2025
Generation of T cell responses against broad KRAS hotspot neoantigens for cell therapy or TCR discoveryBrandon P Conn, Jared L Dietze, Christian J Yee, et al.
European Journal of Immunology|March 24, 2016
Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapySander Kelderman, Bianca Heemskerk, Lorenzo Fanchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2013
HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responsesMarit M van Buuren, Feline E Dijkgraaf, Carsten Linnemann, et al.
Nature Medicine|December 23, 2014
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanomaCarsten Linnemann, Marit M van Buuren, Laura Bies, et al.
Pageof 2